DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Gujarat Ambuja Exports Limited — Outcome of Board Meeting

NSE 1 hr ago·24 Oct 2026, 9:41 am

Gujarat Ambuja Exports

Gujarat Ambuja Exports Limited (GAEL) has announced the outcome of its recent board meeting, disclosing its financial results for the period ending September 30, 2026. This update provides investors with an official confirmation of the company's performance during this quarter.

This disclosure is a standard corporate governance requirement that keeps the market informed about the company's financial health. For investors, these results offer a snapshot of the company's operational efficiency and profitability, helping them assess its current standing before the broader market reacts to the detailed filing.

Investors should now look for the detailed financial statements and management commentary to understand the specific drivers behind the numbers. Key areas to focus on include revenue growth, cost management, and any commentary on future outlook, which will help in evaluating the stock's potential.